Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 10.6.2024ARDEZ Pharma, spol. s r.o. (ARZ)2436DTedez (cps dur 90x0,5 mg/0,4 mg (fľ.HDPE))17.7.2024O
 10.6.2024Viatris Limited (VIM)2252EVixargio 15 mg filmom obalené tablety (tbl flm 98x15 mg (blis.PVC/PVDC/Al))12.6.2024O
 7.6.2024CHEPLAPHARM Arzneimittel GmbH (CEP-1)02130Ubretid 5 mg (tbl 50x5 mg (blis.PVC/PVDC/Al))18.6.2024R
 7.6.2024Dr. Max Pharma s.r.o. (DAX)6903CLoperamid Dr.Max 2 mg (cps dur 20x2 mg (blis.Al/PVC/PVDC))7.6.2024R
 7.6.2024Medreg s.r.o. (MRG-2)2309EGliclazide Medreg 30 mg (tbl plg 120x30 mg (blis.PVC/PVDC/Al))24.4.2024U
 7.6.2024Actavis Group PTC ehf. (ACT-10)01609Telmisartan Actavis 80 mg tablety (tbl 90x80 mg (blis.Al/Al))7.6.2024O
 7.6.2024Teva B.V. (TEV-NL-4)83256Talopam 50 mg (tbl flm 60x50 mg (blis.Al/Al))7.6.2024O
 7.6.2024Teva B.V. (TEV-NL-4)43149Tramadol Retard Actavis 200 mg (tbl plg 30x200 mg (blis.Al/PVC-priehľ.))7.6.2024O
 7.6.2024OMEGA PHARMA a.s. (OMG-1)1937CCOLDREX MAXGRIP LESNÉ OVOCIE (plo por 10x7,6 g (vre.papier/PE/Al/SURLYN))6.6.2024O
 7.6.2024OMEGA PHARMA a.s. (OMG-1)0978DCOLDREX MAXGRIP LESNÉ OVOCIE (plo por 14x7,6 g (vre.papier/PE/Al/SURLYN))6.6.2024U
 6.6.2024Pharmazeutische Fabrik Montavit Ges.m.b.H. (RCW)8112CBaldrian (tbl obd 40x300 mg (blis.PVC/PVDC/Al))6.6.2024R
 6.6.2024Teva B.V. (TEV-NL-4)91376Gabapentin-Teva 300 mg (cps dur 200(2x100)x300 mg (blis.PVC/PVDC/Al))6.6.2024O
 6.6.2024Les Laboratoires Servier (SVE-2)1491APixuvri 29 mg prášok na infúzny koncentrát (plc ifc 1x29 mg (liek.inj.skl.))12.6.2024Z
 6.6.2024Zentiva, k.s. (ZNT-1)28951ZODAC (tbl flm 30x10 mg (blis.PVC/PVDC/Al))7.6.2024O
 6.6.2024Zentiva, k.s. (ZNT-1)3053BTorvacard Novum 20 mg (tbl flm 90x20 mg (blis.OPA/Al/PVC/Al))7.6.2024O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To